Skip to main content
OpenTrials
Completed

NCT Number: NCT02080013

Endovenous Radiofrequency Versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux

our aim is to compare early outcomes following EVL 1320 nm and segmental RF in a randomized study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Endovenous Radiofrequency versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients between the ages of 18 and 60 years with incompetent GSVs documented on duplex ultrasound (US; B-mode and color Doppler imaging) were eligible

Exclusion criteria

  • Exclusion criteria consisted of:
  • Current deep vein thrombosis (DVT)
  • Thrombus in the vein of interest
  • Previous GSV treatment
  • Pregnancy
  • Known malignancy
  • Significant arterial disease (ankle : brachial pressure index below 0•8)
  • Use of anticoagulant medication.

Treatment and study plan

Radiofrequency

Other

ClosureFAST

Other names: ClosureFAST

Primary outcomes

  1. Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Prospective, Randomized Study of Endovenous Segmental Radiofrequency Versus 1320 nm Laser Ablation for the Treatment of Great Saphenous Vein Reflux (RVLAb Study)

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Mar 6, 2014
Registry last updated
Apr 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.